Ottosen
Erik Rytter Ottosen, Olstykke DK
Patent application number | Description | Published |
---|---|---|
20120178740 | HETEROCYCLIC COMPOUNDS AS JAK RECEPTOR AND PROTEIN TYROSINE KINASE INHIBITORS - The invention relates to compounds of general formula (I) wherein A, R | 07-12-2012 |
Lars Ditlev Morck Ottosen, Aarhus N. DK
Patent application number | Description | Published |
---|---|---|
20110183367 | DEVICE AND METHOD FOR NON-INVASIVE MEASUREMENT OF THE INDIVIDUAL METABOLIC RATE OF A SUBSTANTIALLY SPHERICAL METABOLIZING PARTICLE - The present invention relates to methods and devices for non-invasive and non-disturbing measurements of metabolizing rates of substantially spherical metabolizing particles, such as an embryo, and to a method and device for controlling oxygen partial pressure at the level of the embryo. Furthermore, the invention relates to a method for regulating supply of metabolites to a substantially spherical metabolizing particle, as well as a method for selecting substantially spherical metabolizing particles of a predetermined quality. The invention is carried out in a device capable of establishing a diffusion gradient of metabolites between the substantially spherical metabolizing particle inside a compartment in the device and the environment outside the compartment. The metabolizing rate is determined based on information of the metabolite diffusion gradient. | 07-28-2011 |
Martin Ottosen, Kobenhavn V DK
Patent application number | Description | Published |
---|---|---|
20160071135 | METHOD FOR OBTAINING BUSINESS INTELLIGENCE INFORMATION FROM A LARGE DATASET - Behavioural data relating to online interactions is collected and stored in the form of a raw dataset. A data filter created on the basis of defined characteristics of interest is applied to the raw dataset, thereby obtaining a subset of data. Business intelligence analysis is performed on the data of the subset of data, and a business intelligence report is generated, in accordance with the defined characteristics of interest. | 03-10-2016 |
Soren Ottosen, Horsholm DK
Patent application number | Description | Published |
---|---|---|
20150307886 | COMPOSITIONS AND METHODS FOR MODULATION OF FGFR3 EXPRESSION - Disclosed are oligonucleotides which target and hybridize to nucleic acid molecules encoding FGFR3, leading to reduced expression of FGFR3. Reduction in the aberrant expression of FGFR3 is beneficial for the treatment of certain medical disorders, such as achondroplasia. | 10-29-2015 |
Søren Ottosen, Glostrup DK
Patent application number | Description | Published |
---|---|---|
20150368642 | LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES - The invention provides LNA therapeutics oligonucleotide carbohydrate conjugates with considerably enhanced potency, extended therapeutic index and reduced toxicity. | 12-24-2015 |